This is the authors' abstract. We don't add key points for this paper.
The design and synthesis of potent, tripeptidic acylsulfonamide inhibitors of HCV NS3 protease that contain a difluoromethyl cyclopropyl amino acid at P1 are described. A cocrystal structure of 18 with a NS3/4A protease complex suggests the presence of a H-bond between the polarized C–H of the CHF 2 moiety and the backbone carbonyl of Leu135 of the enzyme. Structure–activity relationship studies indicate that this H-bond enhances enzyme inhibitory potency by 13- and 17-fold compared to the CH 3 and CF 3 analogues, respectively, providing insight into the deployment of this unique amino acid.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: